Cardiol Therapeutics (CRDL.TO) Q4 2026 Snapshot: Prices, Volumes & Market Moves
Cardiol Therapeutics (CRDL.TO) dips 0.63% to CAD 1.63, trading 153k shares today. Explore its anti‑inflammatory heart drug pipeline, market cap CAD 181M, and 52‑week performance.
- CARDIOL THERAPEUTICS INC
- Canada
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
One minute to read